- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by National Center of Oncology, Armenia
Total 15231 results
-
European Institute of OncologyUnknownLung CancerItaly, Korea, Republic of, Greece
-
European Institute of OncologyCompleted
-
European Institute of OncologyUnknown
-
European Institute of OncologyUnknownHead and Neck CancerItaly
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Southwest Oncology GroupCompletedProstate CancerUnited States, Canada
-
University of Colorado, DenverNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingMalignant MelanomaUnited States
-
University of Colorado, DenverNational Cancer Institute (NCI); Clovis Oncology, Inc.Active, not recruitingMetastatic Endometrial CancerUnited States
-
Maria Sklodowska-Curie National Research Institute...Lower Silesian Oncology Center; Copernicus Memorial Hospital; Prof. Franciszek...Unknown
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingHead and Neck CancerUnited States, Canada, Saudi Arabia, China
-
NRG OncologyNational Cancer Institute (NCI); Radiation Therapy Oncology GroupActive, not recruitingExtensive Stage Small Cell Lung Carcinoma | Limited Stage Small Cell Lung CarcinomaUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedLymphoma | Neurotoxicity | Radiation Toxicity | Cognitive/Functional Effects | Chemotherapeutic Agent ToxicityUnited States, Israel
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
National Cancer Institute (NCI)NRG Oncology; Radiation Therapy Oncology GroupCompletedAdult Glioblastoma | Adult GliosarcomaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedBreast CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedLung CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedHead and Neck Cancer | XerostomiaUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedSarcoma | Lymphedema | Radiation Toxicity | Radiation Fibrosis | Musculoskeletal ComplicationsUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedProstate CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedCervical Cancer | Endometrial CancerUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyTerminatedPancreatic Adenocarcinoma | Stage III Pancreatic CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Cognitive/Functional EffectsUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompleted
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyWithdrawnTongue Cancer | Stage III Squamous Cell Carcinoma of the Oropharynx | Stage IVA Squamous Cell Carcinoma of the OropharynxUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedHead and Neck CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage I Uterine Corpus Cancer AJCC v8United States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingMetastatic Malignant Neoplasm in the BrainUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingRecurrent Salivary Gland Carcinoma | Stage III Major Salivary Gland Cancer AJCC v8 | Stage IV Major Salivary Gland Cancer AJCC v8 | Metastatic Salivary Gland Carcinoma | Unresectable Salivary Gland CarcinomaUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingAdvanced Head and Neck Squamous Cell Carcinoma | Squamous Cell Carcinoma of Unknown Primary | Advanced Hypopharyngeal Squamous Cell Carcinoma | Advanced Laryngeal Squamous Cell Carcinoma | Advanced Oropharyngeal Squamous Cell CarcinomaUnited States, Canada
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Metastatic Malignant Neoplasm in the Bone | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States, Canada
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Unresectable Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma... and other conditionsUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingMalignant Solid NeoplasmUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyRecruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Unresectable Lung Non-Small Cell Carcinoma | Locally Advanced Lung Non-Small Cell Carcinoma | Locally Recurrent Lung Non-Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | Endometrial Adenocarcinoma | Endometrioid AdenocarcinomaUnited States, Canada
-
National Cancer Institute (NCI)NRG OncologySuspendedOropharyngeal Squamous Cell Carcinoma | Squamous Cell Carcinoma | Basaloid Squamous Cell Carcinoma | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Papillary Squamous Cell Carcinoma | Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC... and other conditionsUnited States, Canada
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States, Canada, Israel, Saudi Arabia
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Squamous Non-Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | HER2-Positive Breast Carcinoma | Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Stage IVA Cervical Cancer AJCC v6 and v7 | Recurrent Cervical Carcinoma | Stage IV Cervical Cancer AJCC v6 and v7 | Stage IVB Cervical Cancer AJCC v6 and v7United States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Recurrent Uterine Corpus Cancer | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer... and other conditionsUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingStage III Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Limited Stage Lung Small Cell Carcinoma | Stage I Lung Cancer AJCC v8United States, Japan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Stage IA Fallopian Tube Cancer AJCC v6 and v7 | Stage IA Ovarian Cancer AJCC v6 and v7 | Stage IB Fallopian Tube Cancer AJCC v6 and v7 | Stage IB Ovarian Cancer AJCC v6 and v7 | Stage IC Fallopian Tube Cancer AJCC v6 and v7 | Stage... and other conditionsUnited States
-
NRG OncologyNational Cancer Institute (NCI)SuspendedStage II Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast CancerUnited States, Canada
-
NRG OncologyNational Cancer Institute (NCI)TerminatedPleural Biphasic Mesothelioma | Pleural Epithelioid Mesothelioma | Stage I Pleural Malignant Mesothelioma AJCC v8 | Stage IA Pleural Malignant Mesothelioma AJCC v8 | Stage IB Pleural Malignant Mesothelioma AJCC v8 | Stage II Pleural Malignant Mesothelioma AJCC v8 | Stage IIIA Pleural Malignant...United States, Canada
-
National Cancer Institute (NCI)NRG OncologyWithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditionsUnited States
-
National Cancer Institute (NCI)NRG OncologyTerminatedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Recurrent Uterine Corpus CancerUnited States